Abstract: Chewable antacid tablet compositions comprising calcium carbonate sweetened with aspartame, and preferably also saccharin wherein said composition is in a solid unit dose form to be ingested by chewing.
Abstract: Disclosed are oral compositions such as toothpastes, mouthrinses, liquid dentifrices, lozenges and gums containing at least one phosphate derivative and a copper source.
Abstract: The present invention provides novel methods for prevention or treatment of primary and recurring squamous cell carcinoma of the oral cavity or oropharynx comprising topical administration, to the oral cavity or oropharynx, of an effective amount of an NSAID, especially a composition administering from about 0.001% to about 0.2% ketorolac to the oral cavity, alone or as an adjunct to surgery and/or radiation therapy.
Abstract: Oral compositions, such as oral gels, toothpastes and mouthwashes, containing a tartaric acid chelating agent and a hydrophobic anionic surfactant.
Abstract: The present invention relates to topical aromatic releasing compositions containing one or more volatile aromatic compounds selected from the group consisting of 3-1-menthoxy propane-1,2-diol, N-substituted-p-menthane-3-carboxamides and acyclic carboxamides and mixtures thereof. In further embodiments, these compositions are also useful for providing relief from nasal symptoms.
Abstract: Disclosed are drink mix compositions comprising a therapeutically effective dose of an anion exchange resin, xanthan gum, and an edible, water soluble salt at a level wherein the gelation rate of the drink mix compositions in a aqueous solution is reduced. These compositions may also contain one or more carriers wherein the compositions are in a form mixable with a liquid to form a suspension of the anion exchange resin, xanthan gum, and edible, water soluble salt.
Abstract: Method for the treatment of human and lower animals having an infectious gastrointestinal disorder, comprising the step of administering from about 50 to about 5000 milligrams of bismuth to said subject, per day, for from 3 to 56 days. Preferred processes also include a step for performing a diagnostic step on the subject for detection of campylobacter-like organism infection of the subject.
Abstract: This invention relates to an oral pharmaceutical composition comprising from about 1% to 75%, by weight, psyllium husk with more than about 97% of the psyllium husk being smaller than about 100 mesh screen; from about 1% to 65%, by weight, cholestyramine; and wherein the ratio of the psyllium husk to the cholestyramine is from about 3:1 to about 1:2, and wherein the composition delivers from 1 g to 30 g of the psyllium husk and from about 4 g to about 30 g of the cholestyramine daily when the composition is taken orally in one or more doses.
Type:
Grant
Filed:
June 2, 1995
Date of Patent:
February 11, 1997
Assignee:
The Procter & Gamble Company
Inventors:
Nabil G. Kardouche, John A. Colliopoulos
Abstract: The subject invention encompasses a transdermally or transmucosally administrable composition for the treatment or nicotine craving or smoking withdrawal symptoms comprising nicotine and caffeine or caffeine equivalent.
Abstract: Oral compositions, such as oral gels, toothpastes and mouthwashes, containing a tartaric acid chelating agent and a hydrophobic anionic surfactant.
Abstract: The present invention relates to orally ingestible, pharmaceutical compositions containing at least one pharmaceutical active and a taste masking component.
Abstract: The present invention relates to immediate release compositions comprising a pre-complex comprising a polymeric polycarboxylate and an aminophenylalkanol vasoconstrictor in a solid chewable matrix of pharmaceutically-acceptable carrier ingredients wherein the aminophenylalkanol vasoconstrictor and polymeric polycarboxylate are in a weight ratio of from about 5:1 to about 1:10 and wherein the pre-complex is dissociable at a pH of from about 4.5 to about 6.8, releasing the aminophenylalkanol vasoconstrictor.
Abstract: Disclosed are denture adhesive compositions possessing improved aesthetics and comprising a component which provides for easy removal of the adhesive from the denture and a hydrophilic powder.
Type:
Grant
Filed:
August 3, 1992
Date of Patent:
August 6, 1996
Assignee:
The Procter & Gamble Company
Inventors:
Jayanth Rajaiah, Abel Saud, Bruce J. MacKay, Dennis R. Grubbs
Abstract: The present invention relates to aqueous oral compositions and methods of use providing improved antimicrobial activity and thereby reducing oral bacteria, mouth malodor and further promoting oral health.
Type:
Grant
Filed:
September 26, 1994
Date of Patent:
July 9, 1996
Assignee:
The Procter & Gamble Company
Inventors:
Cloyd Dixon, Jr., Stephen J. Hunter-Rinderle
Abstract: An ingestible laxative composition comprising specified amounts of dioctyl sulfosuccinate and bulk fiber selected from the group consisting of psyllium, methylcellulose, polycarbophil, calcium polycarbophil, bran, malt soup extract, karaya, guar gum, and mixtures thereof, preferably in single dose form, is described.
Abstract: Improved concentrated liquid pharmaceutical compositions containing acetaminophen wherein said acetaminophen is formed by adding a Beckman rearrangement catalyst to 4-hydroxyacetophenone oxime.